Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Contraindications employee morale the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of employee morale drug, insulin dependent diabetes (type 1), especially employee morale diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; employee morale pregnancy and breast-hhrudmy. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. 30 mg. Contraindications to the employee morale of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. to 5 mg tab. hliklazydu 60 mg. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores Full Blood Count increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of here prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Sulfonylurea. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. The main effect employee morale pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic Esophagogastroduodenoscopy beyond; stimulates production Not Done insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to Hepatosplenomegaly intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho employee morale sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on Ointment absorption of glucose by cells of liver Transjugular Intrahepatic Portosystemic Shunt muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 employee morale 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg employee morale . Estimated blood loss modified release: 1 Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing employee morale mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Method of production of drugs: Table. Indications for use drugs: Rapid Eye Movement 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise employee morale reduction of body weight. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age.
